| Cover | Feb. 16, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Feb. 16, 2022 |
| Entity File Number | 001-39788 |
| Entity Registrant Name | SCOPUS BIOPHARMA INC. |
| Entity Central Index Key | 0001772028 |
| Entity Tax Identification Number | 82-1248020 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 420 Lexington Avenue |
| Entity Address, Address Line Two | Suite 300 |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10170 |
| City Area Code | 212 |
| Local Phone Number | 479-2513 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value |
| Trading Symbol | SCPS |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
